Ingrid C. Kamerling

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: June 15, 2026

Motivations and experiences in controlled human infection trials vs. phase I clinical trials: a survey study.

Motivations and experiences in controlled human infection trials vs. phase I clinical trials: a survey study.

Journal: BMC medical ethics

Published: March 12, 2026

Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.

Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.

Journal: Frontiers in immunology

Published: January 30, 2025

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: September 25, 2024

From setbacks to success: lessons from the journey of RSV vaccine development.

From setbacks to success: lessons from the journey of RSV vaccine development.

Journal: Therapeutic advances in vaccines and immunotherapy

Published: July 12, 2024

Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.

Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.

Journal: Vaccine

Published: January 19, 2024

Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.

Regulatory workshop on challenge strain development and GMP manufacture - A stakeholder meeting report.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: December 06, 2023

Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.

Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.

Journal: Biologicals : journal of the International Association of Biological Standardization

Published: December 06, 2023

Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly.

Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly.

Journal: Vaccine

Published: November 19, 2023

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.

Journal: NPJ vaccines

Published: September 12, 2023

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.

Journal: The Lancet. Infectious diseases

Published: November 16, 2022

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study.

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study.

Journal: Immunologic research

Published: September 26, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026